MedTrace Logo

Develop a Multi-disciplinary Approach for a Personalized Prenatal Diagnostics and Care for Twin Pregnancies

NCT04595214 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2021-10-11

No results posted yet for this study

Summary

Different screening modalities evaluation to develop algorithms to predict pregnancy complications in twin pregnancies, and evaluation of serologic response to BNT162b2 Pfeizer/BioNTech vaccination.

Conditions

  • Prenatal Disorder
  • Premature Birth
  • Twin Pregnancy With Antenatal Problem
  • Twin; Pregnancy, Affecting Fetus or Newborn
  • Twin Pregnancy, Antepartum Condition or Complication
  • Twin Dichorionic Diamniotic Placenta
  • Twin Monochorionic Monoamniotic Placenta

Interventions

OTHER

TTTS cases are treated by intra-uterine laser for separation.

MC twin anaestemosis separatio by laser. Vasa previa and placenta accreta are treated with steroids or other protocols, Positive trisomies by NIPS undergoes CVS or amniocentesis

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Ron Maymon, MD,PhD · Assaf-Harofeh Medical Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-21
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Belgium
  • Canada
  • Germany
  • Israel
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04595214 on ClinicalTrials.gov